The House Energy and Commerce Subcommittee on Health will hold a hearing on Thursday, March 5, 2015 on “Examining the 340B Drug Pricing Program,” focusing on the functionality of the program and the extent to which it meets its goal of improving access to prescription drugs for needy patients at facilities serving these populations. Scheduled witnesses include officials from the Health Resources and Services Administration, the Government Accountability Office, and the Office of the Inspector General.

** Note: this hearing has been rescheduled for March 25.